Otsuka (OTCMKTS:OTSKY) Issues FY 2026 Earnings Guidance

Otsuka (OTCMKTS:OTSKYGet Free Report) issued an update on its FY 2026 earnings guidance on Friday. The company provided EPS guidance of 2.119-2.119 for the period, compared to the consensus EPS estimate of 1.980. The company issued revenue guidance of $17.1 billion-$17.1 billion, compared to the consensus revenue estimate of $16.7 billion.

Otsuka Price Performance

Shares of OTSKY stock opened at $34.41 on Friday. Otsuka has a fifty-two week low of $23.67 and a fifty-two week high of $37.52. The firm has a market capitalization of $36.96 billion and a price-to-earnings ratio of 13.82. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. The stock’s 50-day simple moving average is $34.15 and its 200-day simple moving average is $33.52.

Otsuka (OTCMKTS:OTSKYGet Free Report) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.19. The firm had revenue of $4.41 billion for the quarter, compared to the consensus estimate of $3.95 billion. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. As a group, equities analysts forecast that Otsuka will post 1.96 earnings per share for the current fiscal year.

Otsuka Company Profile

(Get Free Report)

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.

Read More

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.